Andrew McCaskie

Professor Andrew McCaskie is a faculty member at the University of Cambridge, affiliated with the Cambridge Stem Cell Institute and the Division of Trauma and Orthopaedic Surgery. His work focuses on regenerative therapies for bone and cartilage repair, particularly in osteoarthritis affecting 8 million UK patients.

• Role: Director of the Versus Arthritis Tissue Engineering and Regenerative Therapies Centre
• Leadership: Chair of the Cell Therapy Oversight Committee, Director of the Academic Foundation Programme in Cambridge

Research: Combines adult stem cells, tissue engineering, and molecular analysis to address early osteoarthritis and joint destruction mechanisms. Clinical programs include cell therapy trials (e.g., ADIPOA2) and imaging/tissue analysis in cartilage repair surgery.

Key Grants: £2.4M Arthritis Research UK Tissue Engineering Centre (2013-2018), £1.9M Versus Arthritis renewal, £5.1M UK Regenerative Medicine Platform Hub, €5.9M European Commission Horizon 2020 funding.

• Awards: Editor of Bailey and Love's Short Practice of Surgery (27th Edition)
• Collaborations: Midlands and Wales Advanced Therapy Treatment Centre

Students: Supervises PhD students and research staff in regenerative medicine, including Mohammad Alkhrayef and Mark Birch.

Laboratory: Based at Addenbrooke's Hospital, Cambridge Biomedical Campus, with research links to the UK Regenerative Medicine Platform and Versus Arthritis.